Bone Biologics (BBLG) Debt Ratio (2016 - 2017)
Historic Debt Ratio for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to 12.05.
- Bone Biologics' Debt Ratio fell 3789.36% to 12.05 in Q3 2017 from the same period last year, while for Sep 2017 it was 12.05, marking a year-over-year decrease of 3789.36%. This contributed to the annual value of 12.5 for FY2016, which is N/A changed from last year.
- According to the latest figures from Q3 2017, Bone Biologics' Debt Ratio is 12.05, which was down 3789.36% from 21.98 recorded in Q2 2017.
- In the past 5 years, Bone Biologics' Debt Ratio registered a high of 21.98 during Q2 2017, and its lowest value of 11.09 during Q1 2017.